Drug Trial Radar · NCT07449754
Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
Last checked: Nov 20, 2026Latest source record: Mar 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
45
Planned (sponsor's estimate)
Start
Feb 12, 2026
Primary completion
Sep 2029
Study completion Mar 2030
Sponsor
- Lead sponsor
- Hanmi Pharmaceutical Company LimitedIndustry
- Sponsor type
- Industry
- First posted
- Mar 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2 open-label, multicenter, single-arm study evaluating the combination of Belvarafenib and Cobimetinib in patients with locally advanced or metastatic melanoma with NRAS mutations. The study plans to assess ORR, DCR, DOR, TTP, PFS, OS and safety of the participating subjects. Treatment cycles for all subjects will be 28 days in duration and Belvarafenib and Cobimetinib will be administered orally in combination.
Conditions
- Advanced or Metastatic Melanoma
Interventions
BelvarafenibDrug
Belvarafenib will be taken twice daily (BID) on Days 1-28 of each cycle
CobimetinibCombination product
Cobimetinib will be taken on Days 1, 3, 5, 8, 10, 12, 15, 17, and 19 of each cycle (three times weekly, TIW), followed by a drug holiday through Day 28
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response rate (ORR)Time frame: Throughout the study until disease progression or death whichever occurs first (up to approximately 3 years)
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Dong-A University Medical Center
Busan, South Korea · Recruiting
Kyungpook National University Chilgok Hospital
Daegu, South Korea · Not yet recruiting
Chungnam National University Hospital
Daejeon, South Korea · Not yet recruiting
Seoul National University Hospital
Seoul, South Korea · Not yet recruiting
Severance Hospital
Seoul, South Korea · Recruiting
Asan Medical Center
Seoul, South Korea · Recruiting
Samsung Medical Center
Seoul, South Korea · Recruiting
Korea University Guro Hospital
Seoul, South Korea · Not yet recruiting
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea · Not yet recruiting
Chonnam National University Hwasun Hospital
Hwasun, Jeollanam-do, South Korea · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.